Breathe Well Live Well
Condition: Asthma
Interventions: Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo; Biological: CNTO 3157 or placebo
Sponsor: Centocor, Inc.
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Dyspnea
Intervention:
Sponsor: Deep Breeze
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma Patients
Interventions: Drug: AZD1981; Drug: AZD1981; Drug: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Formoterol/Fluticasone; Drug: Foraseq®; Drug: Fluticasone
Sponsor: Eurofarma Laboratorios Ltda
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Salmeterol/Fluticasone; Drug: Seretide
Sponsor: Eurofarma Laboratorios Ltda
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Persistent Allergic Asthma
Interventions: Drug: Omalizumab; Drug: Placebo
Sponsors: Novartis; Genentech
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Intervention: Dietary Supplement: Vitamin D
Sponsor: Florida Atlantic University
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
|
Flu Season May Affect Asthma Patients
WJBF-TV Flu season is just around the corner, and that can be a dangerous time for kids who have asthma. So today the Medical College of Georgia … |
View full post on asthma – Google News
|
ASNC: Regadenoson safe in patients with asthma, COPD
Cardiovascular Business PHILADELPHIA—The use of the pharmacologic stressor regadenoson (Lexiscan, Astellas Pharma) in patients with asthma and chronic obstructive pulmonary … Safety and Tolerability of Regadenoson in Patients With Asthma or COPD |
View full post on asthma – Google News
|
ASNC: Novel Imaging Agent Safe in Airway Disease Patients
MedPage Today PHILADELPHIA — A novel pharmacologic stress agent for myocardial perfusion imaging, apadenoson (Stedivaze), was well tolerated in patients with asthma and … Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic … |
View full post on asthma – Google News